[1]
|
Messinis, I.E., Messini, C.I. and Dafopoulos, K. (2014) Novel Aspects of the Endocrinology of the Menstrual Cycle. Reproductive BioMedicine Online, 28, 714-722. https://doi.org/10.1016/j.rbmo.2014.02.003
|
[2]
|
Limonta, P., Ma-relli, M.M., Moretti, R., Marzagalli, M., Fontana, F. and Maggi, R. (2018) GnRH in the Human Female Reproductive Axis. Vitamins and Hormones, 107, 27-66. https://doi.org/10.1016/bs.vh.2018.01.003
|
[3]
|
Abo, S., Smith, D., Stadt, M. and Layton, A. (2022) Modelling Female Physiology from Head to Toe: Impact of Sex Hormones, Menstrual Cycle, and Pregnancy. Journal of Theoretical Biology, 540, Article ID: 111074.
https://doi.org/10.1016/j.jtbi.2022.111074
|
[4]
|
Bernal, A. and Paolieri, D. (2022) The Influence of Estradiol and Progesterone on Neurocognition during Three Phases of the Menstrual Cycle: Modulating Factors. Behavioural Brain Research, 417, Article ID: 113593.
https://doi.org/10.1016/j.bbr.2021.113593
|
[5]
|
Spierings, E.L. and Padamsee, A. (2015) Menstrual-Cycle and Menstruation Disorders in Episodic vs Chronic Migraine: An Exploratory Study. Pain Medicine, 16, 1426-1432. https://doi.org/10.1111/pme.12788
|
[6]
|
Moscol, G., Espino, P.H., Mayor, L.C. and Burneo, J.G. (2022) Epilepsy with Catamenial Pattern. Revue Neurologique, 74, 303-311.
|
[7]
|
Buse, D.C., Loder, E.W., Gorman, J.A., Stewart, W.F., Reed, M.L., Fanning, K.M., Serrano, D. and Lipton, R.B. (2013) Sex Differences in the Prevalence, Symptoms, and Associated Features of Migraine, Probable Migraine and Other Severe Headache: Results of the American Migraine Prevalence and Prevention (AMPP) Study. Headache, 53, 1278-1299.
https://doi.org/10.1111/head.12150
|
[8]
|
Ahmad, S.R. and Rosendale, N. (2022) Sex and Gender Considerations in Episodic Migraine. Current Pain and Headache Reports, 26, 505-516. https://doi.org/10.1007/s11916-022-01052-8
|
[9]
|
唐钰莎, 陈蕾, 何时旭, 宋婷婷. 基于fMRI探究月经周期与无先兆偏头痛相关性[J]. 医学研究杂志, 2022, 51(4): 54-58.
|
[10]
|
Allais, G., Chiarle, G., Sinigaglia, S., Airola, G., Schiapparelli, P. and Benedetto, C. (2020) Gender-Related Differences in Migraine. Neurological Sciences, 41, 429-436. https://doi.org/10.1007/s10072-020-04643-8
|
[11]
|
Maasumi, K., Tepper, S.J. and Kriegler, J.S. (2017) Menstrual Migraine and Treatment Options: Review. Headache, 57, 194-208. https://doi.org/10.1111/head.12978
|
[12]
|
Nappi, R.E., Tiranini, L., Sacco, S., De Matteis, E., De Icco, R. and Tassorelli, C. (2022) Role of Estrogens in Menstrual Mi-graine. Cells, 11, Article No. 1355. https://doi.org/10.3390/cells11081355
|
[13]
|
赖小燕, 胡幼平, 艾虹静, 王卓慧, 张琪, 吴双, 兰蕾. 雌激素对偏头痛的影响及机制[J]. 中国疼痛医学杂志, 2016, 22(11): 851-853.
|
[14]
|
Petrovski, B., Vetvik, K.G., Lundqvist, C. and Eberhard-Gran, M. (2018) Characteristics of Menstrual versus Non- Menstrual Mi-graine during Pregnancy: A Longitudinal Population-Based Study. The Journal of Headache and Pain, 19, 27-33. https://doi.org/10.1186/s10194-018-0853-3
|
[15]
|
Calhoun, A. (2012) Combined Hormonal Contraceptives: Is It Time to Reassess Their Role in Migraine? Headache, 52, 648-660. https://doi.org/10.1111/j.1526-4610.2011.02051.x
|
[16]
|
Warhurst, S., Rofe, C.J., Brew, B.J., Bateson, D., McGee-chan, K., Merki-Feld, G.S., Garrick, R. and Tomlinson, S.E. (2018) Effectiveness of the Progestin-Only Pill for Migraine Treatment in Women: A Systematic Review and Meta-Analysis. Cephalalgia, 38, 754-764. https://doi.org/10.1177/0333102417710636
|
[17]
|
Amandusson, Å. and Blomqvist, A. (2013) Estrogenic Influences in Pain Processing. Frontiers in Neuroendocrinology, 34, 329-349. https://doi.org/10.1016/j.yfrne.2013.06.001
|
[18]
|
Gu, P., Chen, C., Wu, Q., Dong, C., Wang, T., Wan, Q. and Dong, X. (2021) The Effect and Safety of 5-HT(1F) Receptor Agonist Lasmiditan on Migraine: A Systematic Review and Me-ta-Analysis. BioMed Research International, 2021, Article ID: 6663591. https://doi.org/10.1155/2021/6663591
|
[19]
|
Charbit, A.R., Akerman, S. and Goadsby, P.J. (2010) Dopamine: What’s New in Migraine? Current Opinion in Neurology, 23, 275-281. https://doi.org/10.1097/WCO.0b013e3283378d5c
|
[20]
|
de Vries, T., Villalón, C.M. and Maassen Van Den Brink, A. (2020) Pharmacological Treatment of Migraine: CGRP and 5-HT beyond the Triptans. Pharmacology & Therapeutics, 211, Article ID: 107528.
https://doi.org/10.1016/j.pharmthera.2020.107528
|
[21]
|
Peters, G.L. (2019) Migraine Overview and Summary of Current and Emerging Treatment Options. The American Journal of Managed Care, 25, S23-S34.
|
[22]
|
Ha, H. and Gonzalez, A. (2019) Migraine Headache Prophylaxis. American Family Physician, 99, 17-24.
|
[23]
|
Burch, R. (2020) Epidemiology and Treatment of Menstrual Migraine and Migraine during Pregnancy and Lactation: A Narrative Review. Headache, 60, 200-216. https://doi.org/10.1111/head.13665
|
[24]
|
Johansson, T., Fowler, P., Ek, W.E., Skalkidou, A., Karlsson, T. and Johansson, Å. (2022) Oral Contraceptives, Hormone Replacement Therapy, and Stroke Risk. Stroke, 53, 3107-3115.
https://doi.org/10.1161/STROKEAHA.121.038659
|
[25]
|
吴海燕. 月经相关性癫痫的发病机制及治疗研究进展[J]. 癫痫与神经电生理学杂志, 2018, 27(6): 373-377.
|
[26]
|
王湘庆. 女性癫(痫)临床研究进展解读[J]. 中国现代神经疾病杂志, 2018, 18(5): 310-314.
|
[27]
|
Bosak, M., Słowik, A. and Turaj, W. (2018) Menstrual Disorders and Their Determinants among Women with Epilepsy. Neuropsychiatric Disease and Treatment, 14, 2657-2664. https://doi.org/10.2147/NDT.S179438
|
[28]
|
Taubøll, E., Isojärvi, J.I.T. and Herzog, A.G. (2021) The Interactions between Reproductive Hormones and Epilepsy. Handbook of Clinical Neurology, 182, 155-174. https://doi.org/10.1016/B978-0-12-819973-2.00011-3
|
[29]
|
Joshi, S., Sun, H., Rajasekaran, K., Williamson, J., Pe-rez-Reyes, E. and Kapur, J. (2018) A Novel Therapeutic Approach for Treatment of Catamenial Epilepsy. Neurobiology of Disease, 111, 127-137.
https://doi.org/10.1016/j.nbd.2017.12.009
|
[30]
|
Simpkins, J.W., Singh, M., Brock, C. and Etgen, A.M. (2012) Neuroprotection and Estrogen Receptors. Neuroendocrinology, 96, 119-130. https://doi.org/10.1159/000338409
|
[31]
|
Maguire, M.J. and Nevitt, S.J. (2021) Treatments for Seizures in Catame-nial (Menstrual-Related) Epilepsy. Cochrane Database of Systematic Reviews, 9, Cd013225. https://doi.org/10.1002/14651858.CD013225.pub3
|
[32]
|
Oh, J., Vidal-Jordana, A. and Montalban, X. (2018) Mul-tiple Sclerosis: Clinical Aspects. Current Opinion in Neurology, 31, 752-759. https://doi.org/10.1097/WCO.0000000000000622
|
[33]
|
Mirmosayyeb, O., Badihian, S., Manouchehri, N., Basiri, A.K., Barzegar, M., Esmaeil, N., Fayyazi, E. and Shaygannejad, V. (2018) The Interplay of Multiple Sclerosis and Men-strual Cycle: Which One Affects the Other One? Multiple Sclerosis and Related Disorders, 21, 46-50. https://doi.org/10.1016/j.msard.2018.01.020
|
[34]
|
Pozzilli, C. and Pugliatti, M. (2015) An Overview of Pregnan-cy-Related Issues in Patients with Multiple Sclerosis. European Journal of Neurology, 22, 34-39. https://doi.org/10.1111/ene.12797
|
[35]
|
Nabavi, S.M., Koupai, S.A., Nejati, M.R., Garshasbi, E. and Jalali, M.R. (2010) Menstrual Irregularities and Related Plasma Hormone Levels in Multiple Sclerosis Patients Treated with Beta In-terferone. Acta Medica Iranica, 48, 36-41.
|
[36]
|
Veenman, L. (2020) Raloxifene as Treatment for Various Types of Brain Injuries and Neurodegenerative Diseases: A Good Start. International Journal of Molecular Sciences, 21, Article No. 7586. https://doi.org/10.3390/ijms21207586
|
[37]
|
Cerri, S., Mus, L. and Blandini, F. (2019) Parkinson’s Disease in Women and Men: What’s the Difference? Journal of Parkinson’s Disease, 9, 501-515. https://doi.org/10.3233/JPD-191683
|
[38]
|
Lee, Y.H., Cha, J., Chung, S.J., Yoo, H.S., Sohn, Y.H., Ye, B.S. and Lee, P.H. (2019) Beneficial Effect of Estrogen on Nigrostriatal Dopaminergic Neurons in Drug-Naïve Postmenopausal Parkinson’s Disease. Scientific Reports, 9, Article No. 10531. https://doi.org/10.1038/s41598-019-47026-6
|
[39]
|
Song, Y.J., Li, S.R., Li, X.W., Chen, X., Wei, Z.X., Liu, Q.S. and Cheng, Y. (2020) The Effect of Estrogen Replacement Therapy on Alzheimer’s Disease and Parkinson’s Disease in Postmenopausal Women: A Meta-Analysis. Frontiers in Neuroscience, 14, Article No. 157. https://doi.org/10.3389/fnins.2020.00157
|
[40]
|
Bourque, M., Morissette, M. and Di Paolo, T. (2019) Repurposing Sex Steroids and Related Drugs as Potential Treatment for Parkinson’s Disease. Neuropharmacology, 147, 37-54. https://doi.org/10.1016/j.neuropharm.2018.04.005
|